Intended for healthcare professionals

Corrected table


 

In the paper by Chantal M Morel and colleagues (BMJ 2005;331:1299-302) an error in the cost calculations for malaria treatment in two African regions resulted in an underestimate of the costs of treatment interventions. Correct values for the health maximising set of interventions are given in the revised table 6.

Revised table 6 Costs, effectiveness, and cost effectiveness of the health maximising set of interventions in the two regions Afr-D and Afr-E

Region and intervention

Average yearly costs ($int)

Average yearly effectiveness (DALYs averted)

Average cost effectiveness ($int/DALY averted)

Incremental cost effectiveness ($int/DALY averted)

Afr-D

Insecticide treated bed nets (95% coverage)

178,216,076

8,872,378

29

29

Insecticide treated bed nets plus indoor residual spraying plus case management with artemisinin based combination therapy plus intermittent presumptive treatment in pregnancy (95% coverage)

434,229,098

14,561,792

36

48

Afr-E

Case management with artemisinin based combination therapy (80% coverage)

194,055,200

5,055,437

38

38

Case management with artemisinin based combination therapy plus insecticide treated bed nets (80% coverage)

343,906,545

8,136,888

42

49

Case management with artemisinin based combination therapy plus insecticide treated bed nets (95% coverage)

412,334,271

9,338,292

44

57

Case management with artemisinin based combination therapy plus insecticide treated bed nets plus indoor residual spraying (95% coverage)

509,794,378

10,956,811

46.5

60

Case management with artemisinin based combination therapy plus insecticide treated bed nets plus indoor residual spraying plus intermittent presumptive treatment in pregnancy (95% coverage)

510,921,742

10,964,451

46.6

148

DALY=disability adjusted life year; $int=international dollar.